The Use of Sacubitril/Valsartan for Hospitalized Heart Failure

The editors of JAMA Cardiology place an editorial priority on the valuation of medical advances in addition to the evidence base supporting a medical or device therapy. This is critical to determine the appropriate value-based price benchmarking and priority of novel therapeutics, especially when…

Read the full article here

Related Articles